TCL Archive In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned July 11, 1980
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available March 18, 1994